U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07071974) titled 'A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body' on July 16.
Brief Summary: The main objective of this trial is to investigate relative bioavailability of BI 456906 reference formulation (Formulation A) vs. BI 456906 test formulation (Formulation B2).
Study Start Date: July 28
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 456906 formulation A
BI 456906 formulation A
DRUG: BI 456906 formulation B2
BI 456906 formulation B2
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digital Content Services with permiss...